Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Cancer Diagnosis Program
Contact NExT
Show menu
Search this site

Welcome to the Cancer Diagnosis Program!

The Cancer Diagnosis Program strives to improve the diagnosis and assessment of cancer by effectively moving new scientific knowledge into clinical practice. This national program stimulates, coordinates and funds resources and research for the development of innovative in vitro diagnostics, novel diagnostic technologies and appropriate human specimens in order to better characterize cancers and allow improved medical decision making and evaluation of response to treatment.

For more information about the Cancer Diagnosis Program and its Branches, please click here.

News and Announcements

11/2020
New funding opportunities available! PAR-20-313, PAR-20-314, and PAR-20-074 are now accepting applications.
08/2020
Check out our new funding opportunities from the SBIR! Click here!
10/2019
New publication on submitting diagnostic tissue blocks for NCI clinical trials. Check here for more publications.
08/2019
Check out new funding opportunities from the ITCR! For additional funding opportunities from the CDP, check here.
07/2019
New publication on biostatistical and logistical considerations in the development of basket and umbrella clinical trials. Check here for more publications